Skip to content
Clinical Trials – home
SloveniaBack to Slovenia

Clinical trials in Celje

10 clinical trials in Celje, Slovenia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SloveniaOur site in SloveniaKlinicnaPreskusanja.si(opens in a new tab)
Celje at a glance
10
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

10 trials in Celje

Open in trial search
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG

Crohn's disease

Recruiting
Investigational
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:ABBV-8736
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Colitis ulcerative

Not yet recruiting
Registered drug
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:SloveniaSlovenia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Lutikizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:SloveniaSlovenia
  • Participants:18–64 years
  • Substances:Charcoal, Activated
  • Sponsor:Novartis Pharma AG
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Aminocaproic Acid
  • Sponsor:AstraZeneca AB

Other cities in Slovenia

The busiest research cities in the country

All 17 cities in Slovenia

Clinical research in Celje

What the registry says about research in the country

01 Neurological Disorders

Innovative research focusing on Multiple Sclerosis treatment, evaluating new therapeutic approaches to reduce relapse frequency and improve patient outcomes.

  • Relapsing Multiple Sclerosis
  • Disease Modification Therapy

Comparative studies examining advanced treatment options for neurological conditions.

02 Cardiovascular Medicine

Groundbreaking trials in cardiovascular disease prevention and treatment, including studies on heart failure and atherosclerosis management.

  • Atherosclerotic Cardiovascular Disease
  • Heart Failure Management
  • Stroke Prevention

Focus on reducing major cardiovascular events and improving heart function.

03 Inflammatory Conditions

Comprehensive research into chronic inflammatory diseases, including Hidradenitis Suppurativa and inflammatory bowel conditions.

  • Ulcerative Colitis
  • Crohn's Disease
  • Dermatological Conditions

Testing advanced therapies for moderate to severe inflammatory disorders.

04 Emergency Medicine

Critical studies in anticoagulation management for urgent surgical procedures and emergency medical interventions.

  • Bleeding Management
  • Surgical Hemostasis
  • Emergency Procedures

Evaluating innovative approaches for critical care situations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).